publication date: Dec. 16, 2016

Hackensack Cancer Center, MSKCC Form Business, Clinical Partnership in New Jersey

By Paul Goldberg

Memorial Sloan Kettering Cancer Center and Hackensack Meridian Health announced a 10-year partnership deal that, in its initial stages, will involve developing joint standards of care that will be applied across their operations.

At a later stage, the two organizations intend to create a formal joint venture to own and operate new ambulatory care centers in areas of New Jersey they do not yet serve.

Hackensack Meridian Health operates the John Theurer Cancer Center at HackensackUMC in Hackensack. MSKCC has locations in Basking Ridge, Middletown, and Montvale, which will open in 2018.

“This momentous partnership between the world’s first cancer hospital and New Jersey’s premier hospital system will rewrite the future of cancer care in New Jersey,” Craig Thompson, president and CEO of Memorial Sloan Kettering, said in a statement. “Together, we will provide the best quality and value-based care for our patients, discover new treatments for cancer, and train a new generation of physicians and health professionals for tomorrow.”

MSKCC and Hackensack Meridian Health say they treat one in five New Jersey residents who are diagnosed with cancer. Combined, the two organizations annually will serve the most patients with cancer in the region.

The partnership illustrates the complexities of collaborations between cancer centers as they form business and academic collaborations, which sometimes converge and at other times follow separate paths.

In the academic sphere, John Theurer is developing a consortium cancer center with Georgetown University’s Lombardi Comprehensive Cancer Center in Washington, and the two institutions and are planning to jointly apply for NCI designation in May 2018, which likely means that NCI would act on the application in the spring of … Continue reading Hackensack Cancer Center, MSKCC Form Business, Clinical Partnership in New Jersey

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.